Kliničke studije za Migrena u državi Texas
13 studija za Migrena traži sudionike na lokacijama u državi Texas.
Gradovi u državi Texas
- Austin8 studija
- Houston7 studija
- Dallas5 studija
- El Paso3 studija
- San Antonio3 studija
- Grand Prairie3 studija
Službeni tekst studije (engleski)
Study of EVO756 in Adults With Migraine
- FutureSearch Trials of Neurology, Austin
- FutureSearch Trials of Dallas, Dallas
- SFF Medical Research Group LLC, Houston
- i još 1
U tijeku regrutacijaFaza 2
Od 18 do 64 godina · Oba spola · Ažurirano 2. lis 2026. · NCT07616128Efficacy and Safety Study of Rimegepant for the Preventative Treatment of Migraine in Pediatric Subjects
- Alina Clinical Trials, LLC., Dallas
- North Texas Center for Clinical Research, Frisco
- DM Clinical Research - Cy Fair, Houston
- i još 6
U tijeku regrutacijaFaza 3
Od 6 do 17 godina · Oba spola · Ažurirano 28. ruj 2026. · NCT05156398Long-term Safety Study of Rimegepant in Pediatric Subjects for the Acute Treatment of Migraine
- Dell Children's Medical Center, Austin
- Child Neurology Consultants of Austin - Central Austin, Austin
- Houston Clinical Trials, LLC, Bellaire
- i još 4
U tijeku regrutacijaFaza 3
Od 6 do 17 godina · Oba spola · Ažurirano 24. ruj 2026. · NCT04743141Randomized Study in Children and Adolescents With Migraine: Acute Treatment
- Dell Children's Medical Center, Austin
- Houston Clinical Trials, LLC, Bellaire
- FutureSearch Trials of Dallas, LLC, Dallas
- i još 5
U tijeku regrutacijaFaza 3
Od 6 do 17 godina · Oba spola · Ažurirano 24. ruj 2026. · NCT04649242A Study of Oral Atogepant Tablets to Assess Adverse Events and Change in Disease Activity To Prevent Migraine in Participants Aged 12 to 17 Years
- UT Health Austin at Dell Childrens Neurology Clinic /ID# 270577, Austin
- Earle Research /ID# 270424, Houston
- Clinpoint Trials /ID# 270261, Waxahachie
U tijeku regrutacijaFaza 3
Od 12 do 17 godina · Oba spola · Ažurirano 22. ruj 2026. · NCT06810505Responding With Evidence and Access for Childhood Headaches
- Dell Children's Hospital-UT Health, Austin
U tijeku regrutacija
Od 10 do 17 godina · Oba spola · Ažurirano 21. ruj 2026. · NCT05889624Comparative Effectiveness of Migraine Preventive Medications: The APT Comparison Study
- DHR Health Headache Center, McAllen
U tijeku regrutacijaFaza 4
Od 18 do 70 godina · Oba spola · Ažurirano 16. ruj 2026. · NCT06972056Study to Assess Adverse Events and Disease Activity of Oral Ubrogepant Tablets for the Acute Treatment of Migraine in Children and Adolescents (Ages 6-17)
- UT Health Austin at Dell Children's Neurology Clinic /ID# 244266, Austin
- Austin Regional Clinic - ARC Four Points /ID# 276301, Austin
- Velocity Clinical Research, Austin /ID# 230557, Austin
- i još 13
U tijeku regrutacijaFaza 3
Od 6 do 17 godina · Oba spola · Ažurirano 14. ruj 2026. · NCT05125302A Study to Evaluate the Efficacy and Safety of Elismetrep (K-304) in the Acute Treatment of Migraine
- FutureSearch Trials of Neurology, Austin
- Tekton Research, Austin
- APD Clinical Research, Cypress
- i još 7
U tijeku regrutacijaFaza 3
Od 18 do 75 godina · Oba spola · Ažurirano 20. kol 2026. · NCT07645924A Study With Eptinezumab in Children and Adolescents (6 to 17 Years) With Chronic or Episodic Migraine
- Road Runner Research Ltd, San Antonio
U tijeku regrutacijaFaza 3
Od 6 do 17 godina · Oba spola · Ažurirano 12. lip 2026. · NCT05164172A Study to Investigate the Safety and Efficacy of MEDI0618 Compared to Placebo in Adult Participants With Episodic Migraine
- FutureSearch Trials, Austin
U tijeku regrutacijaFaza 2
Od 18 do 70 godina · Oba spola · Ažurirano 19. svi 2026. · NCT06602479Does Nerve Block + Oral Dexamethasone Reduce Recurrence of Headache Within 72 Hrs?
- University Medical Center of El Paso, El Paso
U tijeku regrutacijaRana faza 1
Od 18 do 85 godina · Oba spola · Ažurirano 6. svi 2026. · NCT06016465Stimulation of External Carotid Artery Circulation
- University of Texas Medical Branch, Galveston
U tijeku regrutacija
Od 18 do 100 godina · Oba spola · Ažurirano 20. velj 2026. · NCT07402954Iz ClinicalTrials.gov, podaci preuzeti 5. lis 2026.. Svaka studija ima svoje uvjete prihoda; tim studije odlučuje tko se može priključiti.